Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining

Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
复制标题

DOI:
10.1158/1055-9965.epi-11-0061
复制
发表时间:
2011-05-01
影响因子:
3.8
通讯作者:
Jemal, Ahmedin
Jemal, Ahmedin
中科院分区:
医学3区
文献类型:
--
作者:
DeSantis, Carol;Howlader, Nadia;Jemal, Ahmedin

文献摘要

被引文献

相似文献

背景:一些出版物报道白人女性的乳腺癌发病率持续下降,从 2002 年到 2003 年下降了约 7%。然而,这些报告都没有专门研究 2003 年之后的趋势。在本文中,我们研究了 2003 年到 2007 年非西班牙裔 (NH) 白人女性的乳腺癌发病率,以确定乳腺癌发病率的下降是否确实持续到 2007 年。此外,我们还提出了乳腺癌发病率新罕布什尔州黑人和西班牙裔妇女的趋势以及所有三个种族/族裔群体的绝经后激素使用情况。方法:使用 2000 年至 2007 年监测、流行病学和最终结果 (SEER) 12 个登记处的数据,按种族/民族、年龄和 ER 状态计算乳腺癌发病率。绝经后激素使用流行率使用 2000 年国家健康访谈调查数据计算, 2005 年和 2008 年。结果:从 2003 年到 2007 年,新罕布什尔州任何年龄组白人女性的总体乳腺癌发病率没有显着变化。然而,40 至 49 岁的 ER+ 乳腺癌发病率增加(每年 2.7%),40 至 49 岁和 60 至 69 岁的 ER- 乳腺癌发病率下降。同样,黑人和西班牙裔女性的总体乳腺癌发病率没有显着变化。从 2005 年到 2008 年,所有群体的激素使用量持续下降,尽管与 2000 年到 2005 年相比下降幅度较小。结论:新罕布什尔州白人女性 2002 年到 2003 年乳腺癌发病率的急剧下降并没有持续到 2007 年。影响:需要进一步研究以更好地了解最近的乳腺癌趋势。癌症流行病学生物标志物20(5); 733-9。 (C) 2011 年 AACR。
Background: Several publications reported breast cancer incidence rates continued to decrease among white women, following the decline of about 7% from 2002 to 2003. However, none of these reports exclusively examined the trend after 2003. In this paper, we examined breast cancer incidence rates among non-Hispanic (NH) white women from 2003 to 2007 to determine whether the decrease in breast cancer incidence rates indeed persisted through 2007. In addition, we present breast cancer incidence trends for NH black and Hispanic women and postmenopausal hormone use for all three racial/ethnic groups.Methods: Breast cancer incidence rates were calculated by race/ethnicity, age and ER status using data from the Surveillance, Epidemiology, and End Results (SEER) 12 registries for 2000 to 2007. Prevalence of postmenopausal hormone use was calculated using National Health Interview Survey data from 2000, 2005, and 2008.Results: From 2003 to 2007, overall breast cancer incidence rates did not change significantly among NH white women in any age group. However, rates increased (2.7% per year) for ER+ breast cancers in ages 40 to 49, and decreased for ER- breast cancers in ages 40 to 49 and 60 to 69. Similarly, overall breast cancer incidence rates did not change significantly for black and Hispanic women. Hormone use continued to decrease from 2005 to 2008 in all groups, although the decreases were smaller compared to those from 2000 to 2005.Conclusions: The sharp decline in breast cancer incidence rates that occurred from 2002 to 2003 among NH white women did not continue through 2007.Impact: Further studies are needed to better understand the recent breast cancer trends. Cancer Epidemiol Biomarkers Prev; 20(5); 733-9. (C) 2011 AACR.